Last updated: December 11, 2023
Sponsor: Cairo University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Dental Filling
Treatment
Placement of BLX implants 2 mm sub-crestal i
Placement of BLX implants equicrestal
Clinical Study ID
NCT06177275
NHR
Ages 21-65 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Eligibility criteria: Inclusion criteria:
- Patients with single missing upper anterior or premolar teeth
- Patients with minimum buccolingual width of 6 mm and mesiodistal width of 6mm
- Patients with healthy systemic conditions.
- Patients older than 18 years.
- Good oral hygiene.
- Accepts one year follow-up period (cooperative patients).
- The patient provides informed consent.
- Adequate Inter-arch space for implant placement.
- Favorable occlusion (no traumatic occlusion).
- Absence of allergy to the prescribed medications.
Exclusion
Exclusion criteria:
- Patients with inadequate bone volume and/ or quality
- Patients with local root remnants
- Patients with inadequate wound healing
- Patients with signs of acute infection related to the area of interest.
- Patients with habits that may jeopardize the implant longevity and affect the resultsof the study such as parafunctional habits (Lobbezoo et al., 2006).
- Heavy smokers patients (more than 10 cigarettes per day) (Lambert, Morris and Ochi, 2000).
- Metabolic diseases such as diabetes or hyperthyroidism as well as systemic medicationssuch as chemotherapy or bisphosphonates
- Pregnant or nursing women.
- Uncooperative patients.
Study Design
Total Participants: 60
Treatment Group(s): 2
Primary Treatment: Placement of BLX implants 2 mm sub-crestal i
Phase:
Study Start date:
December 01, 2023
Estimated Completion Date:
February 01, 2025
Connect with a study center
Faculty of Dentistry, Cairo University
Giza, 00000
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.